Want to see LEGN full AI Analyst Report?
Legend Biotech (LEGN) Financial Statements
Legend Biotech Financial Overview
Legend Biotech's market cap is currently $4.19B. The company's EPS TTM is $-0.50; its P/E ratio is -43.26; Legend Biotech is scheduled to report earnings on November 10, 2026, and the estimated EPS forecast is $-0.00. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.03B | $ 627.24M | $ 285.14M | $ 117.00M | $ 68.83M |
| Gross Profit | $ 620.80M | $ 392.66M | $ 140.93M | $ 51.64M | $ 68.83M |
| Operating Income | $ -136.50M | $ -303.24M | $ -439.49M | $ -455.62M | $ -392.29M |
| EBITDA | $ -232.30M | $ -113.16M | $ -477.87M | $ -416.54M | $ -392.38M |
| Net Income | $ -296.80M | $ -177.03M | $ -518.25M | $ -446.35M | $ -403.58M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 948.60M | $ 1.12B | $ 1.31B | $ 1.03B | $ 882.39M |
| Total Assets | $ 1.73B | $ 1.67B | $ 1.85B | $ 1.33B | $ 1.12B |
| Total Debt | $ 413.70M | $ 350.60M | $ 328.67M | $ 284.53M | $ 122.97M |
| Net Debt | $ -488.20M | $ 63.85M | $ -949.04M | $ -501.50M | $ -565.97M |
| Total Liabilities | $ 731.60M | $ 629.61M | $ 597.24M | $ 586.65M | $ 353.52M |
| Stockholders' Equity | $ 1.00B | $ 1.04B | $ 1.25B | $ 744.31M | $ 765.94M |
| Cash Flow | |||||
| Free Cash Flow | $ -168.04M | $ -158.14M | $ -416.00M | $ -223.56M | $ -243.87M |
| Operating Cash Flow | $ -100.47M | $ -144.03M | $ -393.28M | $ -201.28M | $ -198.47M |
| Investing Cash Flow | $ 711.48M | $ -850.54M | $ 92.79M | $ -77.09M | $ -194.98M |
| Financing Cash Flow | $ -300.79K | $ 5.70M | $ 791.49M | $ 377.98M | $ 626.66M |
Currency in USD